Abstract
Proteolytic degradation of extracellular matrix is a crucial step in the healing of incisional skin wounds. Thus, healing of skin wounds is delayed by either plasminogen-deficiency or by treatment with the broad-spectrum metalloproteinase (MP) inhibitor Galardin alone, while the two perturbations combined completely prevent wound healing. Both urokinase-type plasminogen activator and several matrix metallo proteinases (MMPs), such as MMP-3, -9 and -13, are expressed in the leading-edge keratinocytes of skin wounds, which may account for this phenotypic overlap between these classes of proteases.
| Original language | English |
|---|---|
| Journal | P L o S One |
| Volume | 6 |
| Issue number | 2 |
| Pages (from-to) | e16954 |
| ISSN | 1932-6203 |
| DOIs | |
| Publication status | Published - 2011 |
Keywords
- Animals
- Female
- Male
- Matrix Metalloproteinase 13
- Mice
- Mice, Knockout
- Phenotype
- Plasminogen
- Plasminogen Activators
- Pregnancy
- Signal Transduction
- Skin Diseases
- Survival
- Urokinase-Type Plasminogen Activator
- Wound Healing
Fingerprint
Dive into the research topics of 'Phenotypic overlap between MMP-13 and the plasminogen activation system during wound healing in mice'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS